Clinical Trial TitleHepatitis C virus (HCV) outcomes after treatment with direct acting agents (DAA) in patients with bleeding disorders.
Lisa Boggio, MD
Clinical Trial Protocol Description:
Blood collection for HCV:
- Six months after Baseline Visit
- 1 year after Baseline
- 18 Months after Baseline
- 2 Years after Baseline
Clinical Trial Eligibility Criteria:
In order to participate you must meet the following criteria:
- Are a male or female with hemophilia or other bleeding disorder.
- Are 25 years of age or older.
- Have had exposure to any direct acting agents.
- Have a diagnosis of HCV.
This is a partial list of eligibility requirements.